Mon panier

ActiveMax® Human DLL3 μBeads, premium grade (for cells)DMF

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
MBS-C018-2.5mg
$2210.00
MBS-C018-10mg (2.5mg X 4)
$5875.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Product
    Size
    Amount
    ActiveMax® Human DLL3 μBeads, premium grade (for cells)
    2.5 mg
    2.5×10⁷ beads
    ActiveMax® Human DLL3 μBeads, premium grade (for cells)
    10 mg (2.5 mg×4)
    1.0×10⁸ beads
  • Product Description

    ActiveMax® Human DLL3 μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm in diameter immobilized with Human DLL3 Protein, expressed from human 293 cells (HEK293) and contains AA Ala 27 - Leu 492 (Accession # Q9NYJ7-1).
    ActiveMax® Human DLL3 μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5) , and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

  • Application

    ActiveMax® Human DLL3 μBeads, premium grade (for cells) are designed to stimulate in vitro DLL3-specific CAR-T cells or UCAR-T cells, similar to the tumor cell lines that express human DLL3 antigen. It can be used as follows:
    Evaluating the characteristics of CAR-T cells or UCAR-T cells.
    In vitro expansion of DLL3-specific CAR-T cells or UCAR-T cells.
    In vitro enrichment of DLL3-specific CAR-T cells or UCAR-T cells.

  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage

    This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

    Please protect from light and avoid repeated freeze-thaw cycles. Immediate use after reconstitution is highly recommended.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Important Note

    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

  • Formulation

    Lyophilized in PBS with 0.1% HSA,pH 7.4. Trehalose is added as protectant before lyophilization.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • FACS Data

     DLL3 FACS

    Assay of human DLL3 protein on the μBeads surface by Flow cytometry. The human DLL3 protein conjugated on the μBeads (Cat. No. MBS-C018) surface were fluorescently stained using anti-human DLL3 antibody and PE anti-human IgG Fc Recombinant Antibody, and then analyzed by flow cytometry.

    Protocol

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Delta-like protein 3

  • Catégorie:

  • Nombre de médicaments répertoriés:

    1 Détails

  • Nombre de médicaments cliniques:

    28 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs